Nef and cell signaling transduction: A possible involvement in the pathogenesis of human immunodeficiency virusassociated dementia

Journal of NeuroVirology

Volumn 15, Issue 3, 2009, Pages 238-248

  Bergonzini, Valeria ^a   Calistri, Arianna ^a   Salata, Cristiano ^a   Del Vecchio, Claudia ^a   Sartori, Elena ^a   Parolin, Cristina ^b   Palù, Giogio ^a  

^a Division of Microbiology and Virology   (Netherlands)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

ALK; MAP K; MMP; Nef; Signaling pathways

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CELL PROTEIN; CHEMOKINE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NEF PROTEIN; RANTES; TRANSACTIVATOR PROTEIN; CXCL12 PROTEIN, HUMAN; PROTEIN TYROSINE KINASE; STROMAL CELL DERIVED FACTOR 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMENTIA; DISEASE ASSOCIATION; GLIOBLASTOMA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; NEUROPATHOLOGY; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; TRANSFORMED CELL LINE; TUMOR CELL LINE; VIROLOGY;

AIDS DEMENTIA COMPLEX; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CHEMOKINE CCL5; CHEMOKINE CXCL12; HIV-1; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; RECEPTOR PROTEIN-TYROSINE KINASES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 70450273206     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280902939748     Document Type: Article

References (52)

1. Adle-Biassette H, Levy Y, Colombel M, Poron F, Natchev S, Keohane C, Gray F (1995). Neuronal apoptosis in HIV infection in adults. Neuropathol App Neurobiol 21: 218-227.
2. An SF, Giometto B, Scaravilli T, Tavolato B, Gray F, Scaravilli F (1996). Programmed cell death in brains of HIV-1-positive AIDS and pre-AIDS patients. Acta Neuropathol (Berl) 91: 169-173.
3. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, Pomerantz RJ (1996). Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 6: 573-585.
4. Bergonzini V, Delbue S, Wang JY, Reiss K, Prisco M, Amini S, Khalili K, Peruzzi F (2004). HIV-Tat promotes cellular proliferation and inhibits NGF-induced differentiation through mechanisms involving Id1 regulation. Oncogene 23: 7701-7711.
5. Brabers NA, Nottet HS (2006). Role of the proinflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur J Clin Invest 36: 447-458.
6. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T (2003). Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253: 269-285.
7. Conant K, McArthur JC, Griffin DE, Sjulson L, Wahl LM, Irani DN (1999). Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol 46: 391-398.
8. Cota M, Kleinschmidt A, Ceccherini-Silberstein F, Aloisi F, Mengozzi M, Mantovani A, Brack-Werner R, Poli G (2000). Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1. J NeuroVirol 1: 75-83.
9. Dorfman T, Popova E, Pizzato M, Gottlinger HG (2002). Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix. J Virol 76: 6857-6862
10. Fackler OT, Kienzle N, Kremmer E, Boese A, Schramm B, Klimkait T, Kücherer C, Mueller-Lantzsch N (1997). Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur J Biochem 3: 843-851
11. Fischer-Smith T, Rappaport J (2005). Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Rev Mol Med 7: 1-26.
12. Gonzales-Scarano F, Martin-Garcia J (2005). The neuropathogenesis of AIDS. Nat Rev Immunol 5: 69-81.
13. Gray F, Adle-Biassette H, Chretien F, Lorin de la Grand-maison G, Force G, Keohane C (2001). Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neu-ropathol 4: 146-155.
14. Greenway AL, Holloway G, McPhee DA, Ellis P, Cornall A, Lidman M (2003). HIV-1 Nef control of cell signaling molecules: multiple strategies to promote virus replication. J Biosci 28: 323-335.
15. Greenway AL, McPhee DA, Allen K, Johnstone R, Holloway G, Mills J, Azad A, Sankovich S, Lambert P (2002). Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis. J Virol 76: 2692-2702
16. Hanna Z, Priceputu E, Kay DG, Poudrier J, Chrobak P, Jolicoeur P (2004). In vivo mutational analysis of the N-terminal region of HIV-1 Nef reveals critical motifs for the development of an AIDS-like disease in CD4C/ HIV transgenic mice. Virology 327: 273-286.
17. He JC, Husain M, Sunamoto M, D?Agati VD, Klotman ME, Iyengar R, Klotman PE (2004). Nef stimulates proliferation of glomerular podocytes through activation of Srcdependent Stat3 and MAPK1,2 pathways. J Clin Invest 114: 643-651.
18. Iwahara T, Fujimoto J, Wen D, Cupples R, Bucay N, Arakawa T, Mori S, Ratzkin B, Yamamoto T (1997). Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 14: 439-449.
19. Jung H, Woo MS, Kim SY, Kim WK, Hyun JW, Kim EJ, Kim DH, Kim HS (2006). Ginseng saponin metabolite suppresses phorbol ester-induced matrix metallo-proteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells. Int J Cancer 118: 490-497.
20. Kaplan DR, Miller FD (2000). Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10: 381-391.
21. Kaul M, Garden GA, Lipton SA (2001). Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994.
22. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE (1998). chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 44: 831-835.
23. Kitayama H, Miura Y, Ando Y, Hoshino S, Ishizaka Y, Koyanagi Y (2008). Human immunodeficiency virus type 1 Vpr inhibits axonal outgrowth through induction of mitochondrial dysfunction. J Virol 5: 2528-2542.
24. Kobayashi N (2002). Mechanism of the process formation; podocytes vs. neurons. Microsc Res Tech 57: 217-223.
25. Kobayashi N, Gao SY, Chen J, Saito K, Miyawaki K, Li CY, Pan L, Saito S, Terashita T, Matsuda S (2004). Process formation of the renal glomerular podocyte: is there 71 common molecular machinery for processes of podocytes and neurons? Anat Sci Int 79: 1-10.
26. Kramer-Hammerle S, Hahn A, Brack-Werner R, Werner T (2005). Elucidating effects of long-term expression of HIV-1 Nef on astrocytes by microarray, promoter, and literature analyses. Gene 358: 31-38.
27. Lamant L, Pulford K, Bischof D, Morris SW, Mason DY, Delsol G, Mariame B (2000). Expression of the ALK tyrosine kinase gene in neuroblastoma. Am J Pathol 156: 1711-1721.
28. Linnemann T, Zheng YH, Mandic R, Peterlin BM (2002). Interaction between Nef and phosphatidylinositol-3-kinase leads to activation of p21-activated kinase and increased production of HIV. Virology 294: 246-255
29. Lu TC, He JC, Klotman PE (2007). Podocytes in HIV-associated nephropathy. Nephron Clin Pract 106: 67-71.
30. McArthur JC (2004). HIV dementia: an evolving disease. J Neuroimmunol 157: 3-10.
31. Morooka T, Nishida E (1998). Requirement of p38 mitogen-activated protein kinase for neuronal differentiation in PC12 cells. J Biol Chem 38: 24285-24288.
32. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT (1995). Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin?s lymphoma. Science 267: 316-317.
33. Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Cui X, Witte DP (1997). ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin?s lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 15: 2883-2896.
34. Motegi A, Fujimoto J, Kotani M, Sakuraba H, Yamamoto T (2004). ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth. J Cell Sci 117: 3319-3329
35. Peruzzi F, Bergonzini V, Aprea S, Reiss K, Sawaya BE, Rappaport J, Amini S, Khalili K (2005). Cross talk between growth factors and viral and cellular factors alters neuronal signaling pathways: implication for HIV-associated dementia. Brain Res Rev 50: 114-125
36. Pulford K, Morris SW, Turturro F (2004). Anaplastic lymphoma kinase proteins in growth control and cancer. J Cell Physiol 3: 330-358
37. Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara I, Rain-inko R, Haapasalo H, Krohn K (1995). Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9: 1001-1008.
38. Salata C, Curtarello M, Calistri A, Sartori E, Sette P, de Bernard M, Parolin C, Palu G (2009). vOX2 glycoprotein of human herpesvirus 8 modulates human primary macrophages activity. J Cell Physiol 219: 698-706.
39. Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T, Mori S (1994). Hyperphosphorylation of a novel 80kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 9: 1567-1574.
40. Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M, Mori N, Fujimoto J, Miyauchi J, Mikata A, Nanba K, Takami T, Yamabe H, Takano Y, Izumo T, Nagatani T, Mohri N, Nasu K, Satoh H, Katano H, Fujimoto J, Yamamoto T, Mori S (1995). Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 86: 1954-1960.
41. Souttou B, Carvalho NB, Raulais D, Vigny M (2001). Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway. J Biol Chem 23: 9526-9531.
42. Sporer B, Koedel U, Paul R, Kohleisen B, Erfle V, Fontana A, Pfister HW (2004). Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J Neuroimmunol 102: 125-130.
43. Sporer B, Paul R, Koedel U, Grimm R, Wick M, Goebel FD, Pfister HW (1998). Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. J Infect Dis 178: 854-857.
44. Suryadevara R, Holter S, Borgmann K, Persidsky R, Labenz-Zink C, Persidsky Y, Gendelman HE, Wu L, Ghorpade A (2003). Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia. Glia 44: 47-56.
45. Torres-Munoz J, Stockton P, Tacoronte N, Roberts B, Maronpot RR, Petito CK (2001). Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection. J Neuropathol Exp Neurol 9: 885-892.
46. Trillo-Pazos G, Diamanturos A, Rislove L, Menza T, Chao W, Belem P, Sadiq S, Morgello S, Sharer L, Volsky DJ (2003). Detection of HIV-1 DNA in microglia/macrophages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 2: 144-154.
47. Trillo-Pazos G, McFarlane-Abdulla E, Campbell IC, Pilkington GJ, Everall IP (2000). Recombinant nef HIV-IIIB protein is toxic to human neurons in culture. Brain Res 12: 315-326.
48. Tsareva SA, Moriggl R, Corvinus FM, Wiederanders B, Schutz A, Kovacic B, Friedrich K (2007). Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 9: 279-291.
49. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE (1992). Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31: 349-360.
50. van Marle G, Henry S, Todoruk T, Sullivan A, Silva C, Rourke SB, Holden J, McArthur JC, Gill MJ, Power C (2004). Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 329: 302-318.
51. Wang X, Mori T, Jung JC, Fini ME, Lo EH (2002). Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. J Neurotrauma 19: 615-625.
52. Zamo A, Chiarle R, Piva R, Howes J, Fan Y, Chilosi M, Levy DE, Inghirami G (2002). Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene 21: 1038-1047.